People · Operator
Named in public records as an officer, director or promoter · active 2016–2024 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Scilex Pharmaceuticals Inc. | — | Pharmaceuticals | Series A | $12.5M | $14.9M | 2016 |
| Virpax Pharmaceuticals, Inc. | — | Pharmaceuticals | Seed | $3.9M | $11.8M | 2018 |
Eric Floyd at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Eric Floyd on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Anthony Mack | 2 | 2 |
| Jerrold Sendrow | 2 | 2 |
| Vinay Shah | 1 | 4 |
| Richard B. Cohen | 1 | 3 |
| William Pedranti | 1 | 2 |
| Vanila M. Singh | 1 | 2 |
| Judy M. Su | 1 | 1 |
| Sheila M. Mathias | 1 | 1 |
| Jatinder M. Dhaliwal | 1 | 1 |
| Thani Jambulingam | 1 | 1 |
| Jeffrey Gudin | 1 | 1 |
| Gerald Bruce | 1 | 1 |
| Jerrold B. Sendrow | 1 | 1 |
| Eric P. Floyd | 1 | 1 |
| Anthony P. Mack | 1 | 1 |
| Gary M. Herman | 1 | 1 |
| Katharyn M. Field | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.